349480-83-7 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl imidazo[2,1-b]thiazole-5-carboxylate is used as a key intermediate in the synthesis of various pharmaceutical agents for its potential biological activities. It serves as a precursor in the development of antiviral, antifungal, and antibacterial agents, contributing to the creation of new treatments for infectious diseases.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, ethyl imidazo[2,1-b]thiazole-5-carboxylate is utilized as a building block for designing and synthesizing novel compounds with therapeutic potential. Its unique structural features allow for the exploration of new chemical entities that can target specific biological pathways or receptors.
Used in Coordination Chemistry:
Ethyl imidazo[2,1-b]thiazole-5-carboxylate also finds application as a ligand in coordination chemistry. Its ability to form complexes with metal ions can lead to the development of new materials with unique properties, such as catalytic, electronic, or magnetic functionalities.
Used in Organic Synthesis:
As a versatile precursor in organic synthesis, ethyl imidazo[2,1-b]thiazole-5-carboxylate is employed in the preparation of a wide range of organic compounds. Its reactivity and compatibility with various synthetic methods make it a valuable component in the synthesis of complex organic molecules for various applications, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 349480-83-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,9,4,8 and 0 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 349480-83:
(8*3)+(7*4)+(6*9)+(5*4)+(4*8)+(3*0)+(2*8)+(1*3)=177
177 % 10 = 7
So 349480-83-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O2S/c1-2-12-7(11)6-5-9-8-10(6)3-4-13-8/h3-5H,2H2,1H3
349480-83-7Relevant academic research and scientific papers
3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 44, (2010/02/17)
The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
Page/Page column 25, (2010/09/07)
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as med
TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 80, (2009/03/07)
The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 69, (2008/12/07)
The invention relates to novel 2-aza-bicyclo[3.1.0]hexane derivatives of Formula (I) wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
Page/Page column 50, (2009/01/20)
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
